Assessment of Likely Mass Casualty Events and Potential Hospital Impact
暂无分享,去创建一个
[1] Naoki Masuda,et al. Sarin poisoning in Tokyo subway , 1995, The Lancet.
[2] L. S. Rubin,et al. Effect of sarin on dark adaptation in man: threshold changes. , 1957, Journal of applied physiology.
[3] I. Arita,et al. Four generations of probable person-to-person transmission of human monkeypox. , 1986, American journal of epidemiology.
[4] S. Fujishima,et al. Secondary exposure of medical staff to sarin vapor in the emergency room , 1995, Intensive Care Medicine.
[5] Z. Ježek,et al. Human monkeypox: clinical features of 282 patients. , 1987, The Journal of infectious diseases.
[6] R. J. Johns,et al. Use of oximes in the treatment of intoxication by anticholin-esterase compounds in normal subjects. , 1958, The American journal of medicine.
[7] T Okumura,et al. Report on 640 victims of the Tokyo subway sarin attack. , 1996, Annals of emergency medicine.
[8] J. Markis,et al. Enhancement of drug absorption after administration by an automatic injector , 1974, Journal of Pharmacokinetics and Biopharmaceutics.
[9] L. Martin,et al. Protective effect of diazepam pretreatment on soman-induced brain lesion formation , 1985, Brain Research.
[10] H. Pachter,et al. Two New York City hospitals' surgical response to the September 11, 2001, terrorist attack in New York City. , 2003, The Journal of trauma.
[11] R. Fitzpatrick. eMedicine , 2002, Medical reference services quarterly.
[12] A H Hall,et al. Clinical toxicology of cyanide. , 1986, Annals of emergency medicine.
[13] James Armitage,et al. Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group , 2004, Annals of Internal Medicine.
[14] R. Griesemer,et al. The penetration of an anticholinesterase agent (sarin) into skin. I. Rate of penetration into excised human skin. , 1957, The Journal of investigative dermatology.
[15] J. Esposito,et al. Human monkeypox--Kasai Oriental, Zaire, 1996-1997. , 1997, MMWR. Morbidity and mortality weekly report.
[16] H. Hull,et al. Plague masquerading as gastrointestinal illness. , 1986, The Western journal of medicine.
[17] Rickett Dl,et al. Central respiratory effects versus neuromuscular actions of nerve agents , 1986 .
[18] S. Phillips,et al. Mass medical care with scarce resources: a community planning guide. , 2007 .
[19] J. Breman,et al. Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism. , 1998, The New England journal of medicine.
[20] F. N. Craig,et al. Environmental temperature and the percutaneous absorption of a cholinesterase inhibitor, VX. , 1977, The Journal of investigative dermatology.
[21] M. Kowalczyk,et al. MANAGEMENT OF CONVULSIONS IN NERVE AGENT ACUTE POISONING: A POLISH PERSPECTIVE , 2004 .
[22] S Hinohara,et al. Sarin poisoning on Tokyo subway. , 1997, Southern medical journal.
[23] T Okumura,et al. The Tokyo subway sarin attack: disaster management, Part 2: Hospital response. , 1998, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[24] C. P. Quinn,et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.
[25] P. Jahrling,et al. The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis) , 2001, Laboratory Investigation.
[26] J. Shemer,et al. Blast injuries: bus versus open-air bombings--a comparative study of injuries in survivors of open-air versus confined-space explosions. , 1996, The Journal of trauma.
[27] R. Tauxe,et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. , 1997, JAMA.
[28] P. Wright. An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit , 1954, The Journal of physiology.
[29] B. Mégarbane,et al. Antidotal treatment of cyanide poisoning. , 2003, Journal of the Chinese Medical Association : JCMA.
[30] Michael Mair,et al. Shining light on "Dark Winter". , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] H. W. Casey,et al. Studies of a newly recognized poxvirus of monkeys. , 1969, The Journal of infectious diseases.
[32] Philip K. Russell,et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 2000, JAMA.
[33] S. Krop,et al. Effect of sarin on dark adaptation in man: mechanism of action. , 1957, Journal of applied physiology.
[34] R. Rengstorff. Accidental exposure to sarin: vision effects , 2004, Archives of Toxicology.
[35] K. Friedl,et al. Atropine absorption after intramuscular administration with 2-pralidoxime chloride by two automatic injector devices. , 1989, Journal of pharmaceutical sciences.
[36] K. Kulig,et al. Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. , 1989, Journal de toxicologie clinique et experimentale.
[37] L. Lutwick,et al. Pulmonary manifestations of bioterrorism , 2001, Current infectious disease reports.
[38] M. Keim,et al. Hydroxocobalamin: improved public health readiness for cyanide disasters. , 2001, Annals of emergency medicine.
[39] D. Dennis. Plague as a Biological Weapon , 2009, Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century.
[40] D. Cleri,et al. Plague pneumonia disease caused by Yersinia pestis. , 1997, Seminars in respiratory infections.